Convalescent plasma therapy and mortality in COVID-19 patients admitted to the ICU: a prospective observational study

Clicks: 85
ID: 266608
2021
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
This study aimed to quantify the potential survival benefit of convalescent plasma therapy (CVP) in critically ill patients with acute respiratory failure related to coronavirus disease-2019 (COVID-19).This is a single-center prospective observational ...
Reference Key
schilcher2021annalsconvalescent Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Stefan Hatzl, Florian Posch, Nazanin Sareban, Martin Stradner, Konrad Rosskopf, Alexander C. Reisinger, Philipp Eller, Michael Schörghuber, Wolfgang Toller, Zdenka Sloup, Florian Prüller, Katharina Gütl, Stefan Pilz, Alexander R. Rosenkranz, Hildegard T. Greinix, Robert Krause, Peter Schlenke, Gernot Schilcher;Stefan Hatzl;Florian Posch;Nazanin Sareban;Martin Stradner;Konrad Rosskopf;Alexander C. Reisinger;Philipp Eller;Michael Schörghuber;Wolfgang Toller;Zdenka Sloup;Florian Prüller;Katharina Gütl;Stefan Pilz;Alexander R. Rosenkranz;Hildegard T. Greinix;Robert Krause;Peter Schlenke;Gernot Schilcher;
Journal annals of intensive care
Year 2021
DOI 10.1186/s13613-021-00867-9
URL
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8114671/
Keywords

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.